MEDI vs XLV

Key Takeaways

• Harbor Health Care ETF (MEDI) is a concentrated, actively managed health care fund with approximately 45 holdings and an expense ratio of 0.80%, while State Street Health Care Select Sector SPDR ETF (XLV) is a passive sector ETF tracking the Health Care Select Sector Index with 60 holdings and a lower expense ratio of 0.08%.
• MEDI exhibits higher concentration, with top holdings such as Eli Lilly and Co. representing nearly 20% of assets, compared to XLV’s more diversified exposure across the broader health care sector of the S&P 500.
• Both ETFs target the health care sector but differ in strategy: MEDI emphasizes thematic growth opportunities in pharmaceuticals, biotechnology, and medical devices, whereas XLV provides broad, market-cap-weighted exposure to established health care companies.
• XLV offers superior cost efficiency and liquidity due to its larger assets under management and lower fees, making it suitable for core portfolio allocations, while MEDI’s higher cost reflects its active management approach.
• Sector risks including regulatory changes, drug pricing pressures, and innovation cycles affect both funds, though XLV’s broader diversification may moderate volatility relative to MEDI’s concentrated positions.
• Investors seeking precise sector representation may prefer XLV, while those targeting high-conviction health care growth stories may consider MEDI despite the elevated expense ratio.

Introduction

Harbor Health Care ETF (MEDI) and State Street Health Care Select Sector SPDR ETF (XLV) both provide exposure to the health care sector but pursue distinct strategies. XLV delivers passive, broad-based access to large-cap health care companies within the S&P 500, while MEDI offers a more focused, actively managed approach to health care equities. The comparison highlights differences in cost, concentration, and investment philosophy relevant for investors evaluating sector exposure amid evolving industry dynamics.

Harbor Health Care ETF (MEDI) Overview

Harbor Health Care ETF (MEDI) seeks long-term capital growth by investing primarily in equity securities of health care companies across market capitalizations. The fund holds approximately 45 securities and maintains a concentrated portfolio, with the top 10 holdings accounting for over 59% of assets. Notable positions include Eli Lilly and Co. at roughly 19.8%. MEDI operates as an actively managed thematic fund with an expense ratio of 0.80%. Its strategy emphasizes selective opportunities in pharmaceuticals, biotechnology, and related subsectors rather than broad index replication.

State Street Health Care Select Sector SPDR ETF (XLV) Overview

State Street Health Care Select Sector SPDR ETF (XLV) tracks the Health Care Select Sector Index, which represents the health care sector of the S&P 500. The ETF holds 60 securities and follows a passive, market-cap-weighted methodology. Top holdings typically feature large pharmaceutical and equipment companies. XLV maintains a gross expense ratio of 0.08% and provides quarterly distributions. As a sector Select Sector SPDR, it offers precise, rules-based exposure to pharmaceuticals, health care equipment, providers, biotechnology, and life sciences tools and services.

Industry and Thematic Backdrop

The health care sector encompasses pharmaceuticals, biotechnology, medical devices, and services, influenced by innovation in drug development, aging demographics, and policy developments. Capital flows into the sector respond to earnings cycles, regulatory approvals, and interest rate expectations. Potential risks include drug pricing reforms, patent expirations, and reimbursement pressures. Both ETFs operate within this environment, where technological advances in personalized medicine and digital health continue to shape investment opportunities across market cycles.

Performance and Positioning Comparison

In recent market cycles, XLV has delivered sector-aligned returns with lower volatility due to its broad diversification and large-cap focus. MEDI’s concentrated holdings have produced differentiated performance tied to the success of select growth names, potentially amplifying both upside and downside moves during earnings seasons or sector rotations. Relative positioning reflects XLV’s role as a core health care allocation versus MEDI’s tactical emphasis on high-conviction themes, with cost and liquidity differences influencing long-term suitability.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener for tailored insights.

Tickeron AI Verdict

Based on structural strength, cost efficiency, and diversification profile, Tickeron’s AI would likely favor State Street Health Care Select Sector SPDR ETF (XLV) for most investors due to its lower expense ratio, broader holdings, and established liquidity. Harbor Health Care ETF (MEDI) may appeal in scenarios prioritizing thematic concentration and active selection within health care, though its higher fees introduce greater cost drag over extended periods.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations